Peptide inhibitors of thrombin as potent anticoagulants

Details Peptide inhibitors of thrombin as potent anticoagulants Peptide inhibitors of thrombin as potent anticoagulants

2004-02-27

2008-11-25

Gupta, Anish (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600

Reexamination Certificate

active

07456152

ABSTRACT:
The tetrapeptide Phe-Asn-Pro-Arg (SEQ ID NO: 3) is a structurally-optimized sequence for binding to the active site of thrombin. By conjugating this tetrapeptide or variants thereof to a C-terminal fragment of hirudin, we were able to generate a series of new multivalent inhibitors of thrombin containing only genetically encodable natural amino acids. We found that synergistic binding to both the active site and an exosite of thrombin can be enhanced through substitutions of amino acid residues at the P4, P3and P3′ sites of the active-site directed sequence, Xaa (P4)-Yaa (P3)-Pro (P2)-Arg (P1)-Pro(P1′)-Gln(P2′)-Zaa(P3′). Complementary to rational design, a phage library was constructed to explore further the residue requirements at the P4, P3and P3′ sites for multivalent and optimized bridge-binding. Panning of the phage library has led to thrombin-inhibitory peptides possessing strong anti-cloning activities in the low nanomolar range and yet interfering only partially with the catalytic active site of thrombin. In all, the availability of potent and genetically-encodable polypepticle inhibitors of thrombin opens the door for much wider applications of this clinically-successful class of anticoagulants, e.g. through more cost-effective recombinant peptide production, in areas such as gene therapy as well as to improve clinical efficacy/safety through the incorporation of homing peptides for targeted delivery.

REFERENCES:
patent: 0352228 (1990-01-01), None
patent: WO 03/057258 (2003-07-01), None
Rezaie et al., calcium inhibition of the activation of protein c by thrombin, 1994, Eur J Biochem, v223, pp. 575-579.
Slon-usakiewicz et al., 2000, Biochemistry, v39 pp. 2384-2391.

Affiliated with

Also associated with

Rating

Peptide inhibitors of thrombin as potent anticoagulants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide inhibitors of thrombin as potent anticoagulants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide inhibitors of thrombin as potent anticoagulants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4026942